SOLARA ACTIVE PHA SCI LTD (SOLARA) financials

SOLARA ACTIVE PHA SCI LTD (SOLARA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.[1]It was formed through demerger of API business from Strides Shasun Ltd (currently named as Stride Pharma Sciences). Subsequently, it also acquired the human API business from Sequent Scientific Ltd during the same tim…

  • Market Cap: ₹3,381Cr.
  • Current Price: ₹697
  • Stock P/E: 68.6
  • ROE: -0.11%
  • ROCE: 4.91%
  • Book Value: ₹297
  • Dividend Yield: 0.00%
  • 52W High / Low: ₹774/422

In Sep 2026, SOLARA ACTIVE PHA SCI LTD (SOLARA) reported sales ₹417 Cr and net profit ₹30 Cr.

Annual TTM: sales ₹1,535 Cr, net profit ₹39 Cr.

Shareholding: Promoters 41.93% (Jun 2026), FIIs 11.52% (Jun 2026), DIIs 3.74% (Jun 2026), Public 42.79% (Jun 2026), No. of Shareholders 70,490% (Jun 2026).

SOLARA quarterly results (₹ Cr.)
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales300273319314349387382417
Expenses243230262279312330320340
Operating Profit5843573537586277
OPM %19%16%18%11%11%15%16%18%
Other Income1610-752-4
Interest2729242122272016
Depreciation2524242426262727
Profit before tax8-511-10-17101730
Tax %0%0%0%0%0%0%0%0%
Net Profit8-511-10-17101730
EPS in Rs2.25-1.352.91-2.79-4.822.693.526.10
Raw PDF————————
SOLARA profit and loss (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,3221,6171,2681,4441,2891,2841,3691,535
Expenses1,0651,2321,1871,3091,3841,0801,1821,301
Operating Profit25738581134-95204187234
OPM %19%24%6%9%-7%16%14%15%
Other Income27281422-18490-4
Interest788475901061159486
Depreciation9410811211110399100105
Profit before tax112221-92-45-488-1-739
Tax %0%0%-36%-50%16%0%0%—
Net Profit112221-59-22-567-1-739
EPS in Rs31.4246.13-12.20-4.63-118.10-0.30-2.007.49
Dividend Payout %5%11%0%-49%0%0%0%—
SOLARA balance sheet (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital2736363636404548
Reserves1,0641,5571,4911,4679011,0561,2111,392
Borrowings7226211,0371,0131,012796637542
Other Liabilities339397373379398333384417
Total Liabilities2,1522,6102,9372,8952,3472,2252,2772,400
Fixed Assets1,3741,3591,3341,3421,2611,1871,2311,195
CWIP4088239238256280205208
Investments1818151614222
Other Assets7191,1451,3501,298815757839996
Total Assets2,1522,6102,9372,8952,3472,2252,2772,400
SOLARA cash flows (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity166242154-242156111213153
Cash from Investing Activity-113-359-105-243-81-5-37-50
Cash from Financing Activity-239792334-113-107-180-103
Net Cash Flow30-20142-151-38-0-50
Free Cash Flow107-26-16-4514669173101
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit84%103%49%-276%106%-116%105%83%
SOLARA shareholding pattern (%)
CategorySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters37.27%37.23%37.94%42.01%42.01%42.00%42.00%41.93%
FIIs14.25%14.67%14.63%14.25%13.58%11.98%11.59%11.52%
DIIs3.37%3.19%2.61%2.62%2.69%3.64%3.75%3.74%
Public45.11%44.92%44.82%41.10%41.71%42.37%42.66%42.79%
No. of Shareholders71,88283,14875,79174,33472,47971,89070,40070,490
SOLARA key ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days76631091411369993117
Inventory Days111170149321258163185170
Days Payable126131154150139140141143
Cash Conversion Cycle62102104312256123137144
Working Capital Days-20-30173922-129-61-22
ROCE %10%12%15%-1%2%-9%6%5%
SOLARAUpdated 18 Oct 2026, 20:10

Solara Active Pha Sci Ltd

Market Cap

₹3,381Cr.

Current Price

₹697

High / Low

₹774/422

Stock P/E

68.6

ROE-0.11%
ROCE4.91%
Book Value₹297
Face Value₹10.0
Dividend Yield0.00%

About

Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.[1]It was formed through demerger of API business from Strides Shasun Ltd (currently named as Stride Pharma Sciences). Subsequently, it also acquired the human API business from Sequent Scientific Ltd during the same time, making it a pure play API company.[2]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days18576631091411369993117
Inventory Days252111170149321258163185170
Days Payable420126131154150139140141143
Cash Conversion Cycle1762102104312256123137144
Working Capital Days-120-20-30173922-129-61-22
ROCE %—10%12%15%-1%2%-9%6%5%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SOLARA ACTIVE PHA SCI LTD (SOLARA)?

The reported market capitalisation for SOLARA ACTIVE PHA SCI LTD (SOLARA) is ₹3,381Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SOLARA?

The current price shown for SOLARA ACTIVE PHA SCI LTD (SOLARA) on Fincrux is ₹697 with a 52-week high/low of ₹774/422.

What is the P/E ratio of SOLARA ACTIVE PHA SCI LTD (SOLARA)?

The stock P/E for SOLARA ACTIVE PHA SCI LTD (SOLARA) is 68.6 on Fincrux, with ROE at -0.11% and ROCE at 4.91%.

What were SOLARA latest quarterly results?

For Sep 2026, SOLARA ACTIVE PHA SCI LTD (SOLARA) reported sales ₹417 Cr and net profit ₹30 Cr (figures in ₹ crore unless noted).

What are SOLARA annual sales and net profit?

For TTM, SOLARA ACTIVE PHA SCI LTD (SOLARA) shows sales of ₹1,535 Cr and net profit of ₹39 Cr on the Fincrux profit & loss statement.

Who owns SOLARA ACTIVE PHA SCI LTD (SOLARA)?

Latest shareholding for SOLARA ACTIVE PHA SCI LTD (SOLARA) on Fincrux: Promoters 41.93% (Jun 2026), FIIs 11.52% (Jun 2026), DIIs 3.74% (Jun 2026), Public 42.79% (Jun 2026), No. of Shareholders 70,490% (Jun 2026).

Where can I find SOLARA ACTIVE PHA SCI LTD (SOLARA) financials?

SOLARA ACTIVE PHA SCI LTD (SOLARA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SOLARA balance sheet and cash flow?

Yes. The SOLARA ACTIVE PHA SCI LTD (SOLARA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 20:10


Designed & Shipped by Harshit Bansal